(Q43633513)

25 November 2017

title

Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease (English)

1 reference

25 November 2017

0 references

Tuppo EE

1

1 reference

25 November 2017

Forman LJ

2

1 reference

25 November 2017

Spur BW

3

1 reference

25 November 2017

Chan-Ting RE

4

1 reference

25 November 2017

Chopra A

5

1 reference

25 November 2017

Cavalieri TA

6

1 reference

25 November 2017

publication date

1 March 2001

1 reference

25 November 2017

published in

Brain Research Bulletin

1 reference

25 November 2017

volume

54

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

565-568

1 reference

Estimated prevalence of Alzheimer's disease in the United States

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Increased nuclear DNA oxidation in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Increased CSF F2-isoprostane concentration in probable AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

The isoprostanes: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900450-6

7 January 2021

10.1016/S0361-9230(01)00450-6

Identifiers

DOI

1 reference

25 November 2017

1 reference